These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 21786171
1. Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator. Heath L, Ling S, Racz J, Mane G, Schmidt L, Myers JL, Tsai WC, Caruthers RL, Hirsch JC, Stringer KA. Pediatr Cardiol; 2011 Dec; 32(8):1182-9. PubMed ID: 21786171 [Abstract] [Full Text] [Related]
2. Strategies to Prevent Cast Formation in Patients with Plastic Bronchitis Undergoing Heart Transplantation. Parent JJ, Darragh RK, Gossett JG, Ryan TD, Villa CR, Lorts A, Jefferies JL, Towbin JA, Chin C. Pediatr Cardiol; 2017 Jun; 38(5):1077-1079. PubMed ID: 28101662 [Abstract] [Full Text] [Related]
3. Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway casts. Racz J, Mane G, Ford M, Schmidt L, Myers J, Standiford TJ, Schumacher KR, Fifer C, Russell MW, Stringer KA. Ann Am Thorac Soc; 2013 Apr; 10(2):98-107. PubMed ID: 23607837 [Abstract] [Full Text] [Related]
4. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature. Do TB, Chu JM, Berdjis F, Anas NG. Pediatr Cardiol; 2009 Apr; 30(3):352-5. PubMed ID: 19005718 [Abstract] [Full Text] [Related]
5. Plastic bronchitis after extracardiac Fontan operation. Grutter G, Di Carlo D, Gandolfo F, Adorisio R, Alfieri S, Michielon G, Carotti A, Pongiglione G. Ann Thorac Surg; 2012 Sep; 94(3):860-4. PubMed ID: 22698771 [Abstract] [Full Text] [Related]
6. Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. Costello JM, Steinhorn D, McColley S, Gerber ME, Kumar SP. Pediatrics; 2002 Apr; 109(4):e67. PubMed ID: 11927740 [Abstract] [Full Text] [Related]
8. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, Holmes WW, White CW. Toxicol Sci; 2015 Jan; 143(1):178-84. PubMed ID: 25331496 [Abstract] [Full Text] [Related]
9. Management of plastic bronchitis with topical tissue-type plasminogen activator. Gibb E, Blount R, Lewis N, Nielson D, Church G, Jones K, Ly N. Pediatrics; 2012 Aug; 130(2):e446-50. PubMed ID: 22802609 [Abstract] [Full Text] [Related]
10. Successful management of plastic bronchitis in a child post Fontan: case report and literature review. Do P, Randhawa I, Chin T, Parsapour K, Nussbaum E. Lung; 2012 Aug; 190(4):463-8. PubMed ID: 22430124 [Abstract] [Full Text] [Related]
13. A case of plastic bronchitis presenting 9 years after Fontan. Zaccagni HJ, Kirchner L, Brownlee J, Bloom K. Pediatr Cardiol; 2008 Jan; 29(1):157-9. PubMed ID: 17929079 [Abstract] [Full Text] [Related]
14. A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation. Avitabile CM, Goldberg DJ, Dodds K, Dori Y, Ravishankar C, Rychik J. Ann Thorac Surg; 2014 Aug; 98(2):634-40. PubMed ID: 24841545 [Abstract] [Full Text] [Related]
17. Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Am J Respir Cell Mol Biol; 2013 Apr; 48(4):439-47. PubMed ID: 23258228 [Abstract] [Full Text] [Related]
18. Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient. Wakeham MK, Van Bergen AH, Torero LE, Akhter J. Pediatr Crit Care Med; 2005 Jan; 6(1):76-8. PubMed ID: 15636664 [Abstract] [Full Text] [Related]